ArticleFrontiers in immunology2026

Engineering of induced pluripotent stem cells for the efficient development of non-alloreactive, hypoimmunogenic CD8αβ CAR-T cells.

Alexandros Nianias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.